Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Apr 2016 16:00

EKF Diagnostics appoints chairman

(ShareCast News) - The AIM-listed point-of-care business EKF Diagnostics Holdings has appointed Christopher Mills as non-executive chairman with immediate effect. The incoming chairman is chief executive and the sole shareholder of Harwood Capital Management Limited and founder of JO Hambro. Mills

Read more
8 Apr 2016 08:54

EKF Hires New Non-Executive Chairman After 5-Month Stint By Zwanziger

Read more
6 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Apr 2016 15:02

Earnings, Trading Statements Calendar - Week Ahead

Read more
29 Mar 2016 15:12

AGM, EGM Calendar - Week Ahead

Read more
4 Feb 2016 16:32

Frontier Resources Set To Raise GBP1.4 Million, Get New Chairman (ALLISS)

Read more
3 Feb 2016 13:04

EKF Diagnostics kitchen-sinking will drive break-even 'by April'

(ShareCast News) - Shares in EKF Diagnostics bounced off their all-time low thanks to a trading update that reiterated full-year profit guidance and emphasised its total focus on point-of-care. After a dark end to 2015, in which one director died and the company announced a significant profit warnin

Read more
3 Feb 2016 09:45

EKF Diagnostics Makes Cost-Savings To Counter Profit Hit

Read more
23 Dec 2015 14:27

EKF admits defeat with Selah acquisition

(ShareCast News) - EKF Diagnostics Holdings all but admitted defeat in its experiment with personalised medicine on Wednesday, as it let go of its wholly-owned subsidiary Selah back to the founders. The AIM-listed medical diagnostic business confirmed it had reached agreement to sell the US-based de

Read more
23 Dec 2015 07:41

EKF Diagnostics Sells Loss-Making Selah Genomics To Founders

Read more
22 Dec 2015 14:27

Chairman Backs EKF Diagnostics With GBP3.0 Million Convertible Loan

Read more
14 Dec 2015 13:05

DIRECTOR DEALINGS: EKF Diagnostics Finance Boss Buys Before Departure

Read more
10 Dec 2015 08:35

EKF Diagnostics Chief Technology Officer Bacarese-Hamilton Resigns

Read more
2 Dec 2015 14:46

EKF Diagnostics Holdings Finance Director Resigns

Read more
26 Nov 2015 11:59

LONDON MARKET MIDDAY: Possible China Short-Selling Probe Lifts Miners

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.